OVERVIEW

Immunology

As a complex network of cells and proteins throughout the body, the immune system helps our body to defend itself against infections.

In some cases, the immune system can be over-active, resulting in an excessive immune response against substances in the environment (such as with allergic reactions) or a response to normal components of the body (such as in autoimmune diseases). 

Researchers at TRI are studying the processes behind immunological disorders such as autoimmune disorders and bone and joint disorders, and ways we can train the immune system to target cancer cells via immunotherapies.

Image: Lymphocyte illustration (Big Stock Photo: urfingus ID123040430)

Key Researchers
 
Tim Wells
Allison Pettit
Antje Blumenthal
David Evans
Graham Robert Leggatt
Kristen Radford
Matthew Arthur Brown
Michael McGuckin
Ranjeny Thomas
Raymond John Steptoe
Stephen Robert Mattarollo
Show More ...
IMMUNOLOGY RESEARCH PROGRAMS
Click a program below to learn more
 
Autoimmune and Autoinflammatory Diseases
Bone and Joint Diseases
Immunotherapies
Inflammatory Bowel Disease
Article
Clinician-researcher focuses on patients with rare lymphoma Haematologist, Dr Colm Keane, has a clear focus on improving patient outcomes through his lymphoma research program at the Translational...Read more
Article
Aussie invention propelling needle-free vaccine delivery The Translational Research Institute is home to Australian biotech, Vaxxas, which is set to both disrupt and revolutionise vaccine delivery...Read more
Article
Awakening the immune system to fight diseases Scientists at The Translational Research Institute (TRI) are harnessing the body’s front-line immune cells to fight cancer, with potential new...Read more
Article
New autoimmune disease and cancer therapeutics edging closer to reality for patients A career dedicated to rheumatoid arthritis has led Professor Ranjeny Thomas AM to the development of a potential...Read more
Article
CSL signs deal for new autoimmune disease therapeutic Biotech leader, CSL has announced a partnership deal to develop and commercialise an autoimmune disease therapeutic developed by The University...Read more
Article
A drug currently in clinical trials has the potential to improve the survival rate of Australians diagnosed with acute myeloid leukaemia, following the outcomes of preclinical research by Mater...Read more
Article
Largest microarray patch clinical vaccination study ever performed Immune response significantly higher, faster Vaccine shown to be stable for 12 months at temperatures as high as 40 o C Vaxxas...Read more
Article
TRI-based researchers from The University of Queensland (UQ) were involved in discovering how joint inflammation evolves in rheumatoid arthritis, and the cells that prolong the inflammatory attack...Read more
Article
Reduced immune infiltration into nodes associated with poor outcomes in follicular lymphoma Research published today in the highly prestigious Journal of Clinical Oncology by Mater Research CEO and...Read more
Article
Can a patient’s own immune cells be modified to cure a rare and deadly type of lymphoma? Professor Maher Gandhi, CEO of Mater Research and Director of Mater Research Institute-UQ, is leading a...Read more

Pages